Cediprof Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CEDIPROF INC, and what generic and branded alternatives to CEDIPROF INC drugs are available?
CEDIPROF INC has four approved drugs.
Drugs and US Patents for Cediprof Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-005 | Mar 1, 2002 | AB1,AB2,AB3 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Cediprof Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET;ORAL | 208737-003 | Feb 1, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Cediprof Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | TABLET;ORAL | 208737-001 | Feb 1, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Cediprof Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-007 | Mar 1, 2002 | 6,399,101 | ⤷ Try a Trial |
Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-003 | Mar 1, 2002 | 6,399,101 | ⤷ Try a Trial |
Cediprof Inc | LEVO-T | levothyroxine sodium | TABLET;ORAL | 021342-001 | Mar 1, 2002 | 6,399,101 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.